J. Bach, Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease, Endocrine Reviews, vol.15, issue.4, pp.516-542, 1994.
DOI : 10.1210/edrv-15-4-516

G. Feutren, L. Papoz, R. Assan, B. Vialettes, G. Karsenty et al., Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial, Lancet, vol.2, pp.119-124, 1986.

I. Raz, D. Elias, A. Avron, M. Tamir, M. Metzger et al., ??-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, The Lancet, vol.358, issue.9295, pp.1749-1753, 2001.
DOI : 10.1016/S0140-6736(01)06801-5

E. Lampeter, A. Klinghammer, W. Scherbaum, E. Heinze, B. Haastert et al., The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group, Diabetes, vol.47, issue.6, pp.980-984, 1998.
DOI : 10.2337/diabetes.47.6.980

L. Chaillous, H. Lefevre, C. Thivolet, C. Boitard, N. Lahlou et al., Oral insulin administration and residual (??-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, The Lancet, vol.356, issue.9229, pp.545-549, 2000.
DOI : 10.1016/S0140-6736(00)02579-4

P. Pozzilli, D. Pitocco, N. Visalli, M. Cavallo, R. Buzzetti et al., No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII), Diabetologia, vol.43, issue.8, pp.1000-1004, 2000.
DOI : 10.1007/s001250051482

H. Allen, G. Klingensmith, P. Jensen, E. Simoes, A. Hayward et al., Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study, Diabetes Care, vol.22, issue.10, pp.1703-1707, 1999.
DOI : 10.2337/diacare.22.10.1703

H. Weiner, A. Friedman, A. Miller, S. Khoury, A. Sabbagh et al., Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens, Annual Review of Immunology, vol.12, issue.1, pp.809-837, 1994.
DOI : 10.1146/annurev.iy.12.040194.004113

T. Maki, T. Ichikawa, R. Blanco, and J. Porter, Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum., Proceedings of the National Academy of Sciences, vol.89, issue.8, pp.3434-3438, 1992.
DOI : 10.1073/pnas.89.8.3434

Y. Wang, L. Hao, R. Gill, and K. Lafferty, Autoimmune Diabetes in NOD Mouse Is L3T4 T-Lymphocyte Dependent, Diabetes, vol.36, issue.4, pp.535-538, 1987.
DOI : 10.2337/diab.36.4.535

P. Sempe, P. Bedossa, M. Richard, M. Villa, J. Bach et al., Anti-??/?? T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice, European Journal of Immunology, vol.85, issue.5, pp.1163-1169, 1991.
DOI : 10.1002/eji.1830210511

H. Acha-orbea, D. Mitchell, L. Timmermann, D. Wraith, G. Tausch et al., Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention, Cell, vol.54, issue.2, pp.263-273, 1988.
DOI : 10.1016/0092-8674(88)90558-2

B. Conrad, R. Weissmahr, J. Boni, R. Arcari, J. Schupbach et al., A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes, Cell, vol.90, issue.2, pp.303-313, 1997.
DOI : 10.1016/S0092-8674(00)80338-4

R. Slattery, L. Kjer-nielsen, A. J. , C. B. Mandel, T. Miller et al., Prevention of diabetes in non-obese diabetic I-Ak transgenic mice, Nature, vol.345, issue.6277, pp.724-726, 1990.
DOI : 10.1038/345724a0

S. Singer, R. Tisch, X. Yang, H. Mcdevitt, D. Lenschow et al., An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes, pp.9566-9570285, 1993.
DOI : 10.1073/pnas.90.20.9566

B. Salomon, D. Lenschow, L. Rhee, N. Ashourian, B. Singh et al., B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes, Immunity, vol.12, issue.4, pp.431-440, 2000.
DOI : 10.1016/S1074-7613(00)80195-8

B. Hultgren, X. Huang, N. Dybdal, and T. Stewart, Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice, Diabetes, vol.45, issue.6, pp.812-817, 1996.
DOI : 10.2337/diabetes.45.6.812

D. Serreze, C. Post, H. Chapman, E. Johnson, B. Lu et al., Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice, Diabetes, vol.49, issue.12, pp.2007-2011, 2000.
DOI : 10.2337/diabetes.49.12.2007

S. Trembleau, G. Penna, S. Gregori, H. Chapman, D. Serreze et al., Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice, J Immunol, vol.163, pp.2960-2968, 1999.

L. Wogensen, M. Lee, and N. Sarvetnick, Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice, Journal of Experimental Medicine, vol.179, issue.4, pp.1379-1384, 1994.
DOI : 10.1084/jem.179.4.1379

X. Zheng, A. Steele, W. Hancock, A. Stevens, P. Nickerson et al., A noncytolytic IL- 10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice, J Immunol, vol.158, pp.4507-4513, 1997.

F. Zavala, A. Masson, K. Hadaya, S. Ezine, E. Schneider et al., Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice, J Immunol, vol.163, pp.5125-5132, 1999.

C. Jacob, S. Aiso, S. Michie, and H. Mcdevitt, Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1., Proceedings of the National Academy of Sciences, vol.87, issue.3, pp.968-972, 1990.
DOI : 10.1073/pnas.87.3.968

X. Yang, R. Tisch, S. Singer, Z. Cao, R. Liblau et al., Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process, Journal of Experimental Medicine, vol.180, issue.3, pp.995-1004, 1994.
DOI : 10.1084/jem.180.3.995

L. Chatenoud, E. Thervet, J. Primo, and J. Bach, Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice., Proceedings of the National Academy of Sciences, vol.91, issue.1, pp.123-127, 1994.
DOI : 10.1073/pnas.91.1.123

L. Chatenoud, J. Primo, and J. Bach, CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice, J Immunol, vol.158, pp.2947-2954, 1997.

P. Hutchings, O. Reilly, L. Parish, N. Waldmann, H. Cooke et al., The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to ?? cells in NOD mice, European Journal of Immunology, vol.18, issue.7, pp.1913-1918, 1992.
DOI : 10.1002/eji.1830220735

H. Waldmann and S. Cobbold, HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?, Annual Review of Immunology, vol.16, issue.1, pp.619-644, 1998.
DOI : 10.1146/annurev.immunol.16.1.619

J. Gombert, A. Herbelin, E. Tancrede-bohin, M. Dy, C. Carnaud et al., Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, European Journal of Immunology, vol.19, issue.12, pp.2989-2998, 1996.
DOI : 10.1002/eji.1830261226

S. Sharif, G. Arraeza, P. Zucker, Q. Mi, J. Sondhi et al., Herbelin A: Activation of natural killer T cells by ? ?-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nature Medicine, vol.7, issue.9, pp.1057-1062, 2001.
DOI : 10.1038/nm0901-1057

L. Harrison, M. Dempsey-collier, D. Kramer, and K. Takahashi, Aerosol Insulin Induces Regulatory CD8 gamma delta T Cells That Prevent Murine Insulin-dependent Diabetes, Journal of Experimental Medicine, vol.184, issue.6, pp.2167-2174, 1996.
DOI : 10.1084/jem.184.6.2167

H. Qin, M. Sadelain, C. Hitchon, J. Lauzon, and B. Singh, Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice, J Immunol, vol.150, pp.2072-2080, 1993.

A. Bendelac, C. Boitard, J. Bach, and C. Carnaud, Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice, European Journal of Immunology, vol.213, issue.4, pp.611-616, 1989.
DOI : 10.1002/eji.1830190406

A. Ito, N. Aoyanagi, and T. Maki, Regulation of Autoimmune Diabetes by Interleukin 3-dependent Bone Marrow-derived Cells in NOD Mice, Journal of Autoimmunity, vol.10, issue.4, pp.331-338, 1997.
DOI : 10.1006/jaut.1997.0142

I. Gerling, D. Serreze, S. Christianson, and E. Leiter, Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice, Diabetes, vol.41, issue.12, pp.1672-1676, 1992.
DOI : 10.2337/diabetes.41.12.1672

B. Charlton, C. Taylor-edwards, R. Tisch, and C. Fathman, Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD Mice, Journal of Autoimmunity, vol.7, issue.5, pp.549-560, 1994.
DOI : 10.1006/jaut.1994.1040

J. Shizuru, C. Taylor-edwards, B. Banks, A. Gregory, and C. Fathman, Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes, Science, vol.240, issue.4852, pp.659-662, 1988.
DOI : 10.1126/science.2966437

P. Hutchings, E. Simpson, O. Reilly, L. Lund, T. Waldmann et al., The involvement of Ly 2+ T cells in beta cell destruction, Journal of Autoimmunity, vol.3, pp.101-109, 1990.
DOI : 10.1016/S0896-8411(09)90018-X

L. Weiss, S. Slavin, S. Reich, P. Cohen, S. Shuster et al., Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody, Proceedings of the National Academy of Sciences, vol.42, issue.4, pp.285-290, 2000.
DOI : 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z

P. Sempe, S. Ezine, J. Marvel, P. Bedossa, M. Richard et al., T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse, International Immunology, vol.5, issue.5, pp.479-489, 1993.
DOI : 10.1093/intimm/5.5.479

M. Abu-hadid, A. Lazarovits, and J. Madrenas, Prevention of Diabetes Mellitus in the Non-obese Diabetic Mouse Strain with Monoclonal Antibodies Against the CD45RB Molecule, Autoimmunity, vol.20, issue.1, pp.73-76, 2000.
DOI : 10.3109/08916930008995990

M. Harada and S. Makino, Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody, Jikken Dobutsu, vol.4, pp.501-504, 1986.

M. Ogawa, T. Maruyama, T. Hasegawa, T. Kanaya, F. Kobayashi et al., <b>The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) </b><b>mice </b>, Biomedical Research, vol.6, issue.2, pp.103-105, 1985.
DOI : 10.2220/biomedres.6.103

G. Johnson, A. Mikulowska, E. Butcher, L. Mcevoy, and S. Michie, Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice, J Immunol, vol.163, pp.5678-5685, 1999.

K. Tsukamoto, K. Yokono, K. Amano, M. Nagata, N. Yagi et al., Administration of Monoclonal Antibodies against Vascular Cell Adhesion Molecule-1/Very Late Antigen-4 Abrogates Predisposing Autoimmune Diabetes in NOD Mice, Cellular Immunology, vol.165, issue.2, pp.193-201, 1995.
DOI : 10.1006/cimm.1995.1205

X. Yang, N. Karin, R. Tisch, L. Steinman, and H. Mcdevitt, Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors., Proceedings of the National Academy of Sciences, vol.90, issue.22, pp.10494-10498, 1993.
DOI : 10.1073/pnas.90.22.10494

A. Jakubowski, B. Ehrenfels, R. Pepinsky, and L. Burkly, Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice, J Immunol, vol.155, pp.938-946, 1995.

Y. Mori, M. Suko, H. Okudaira, I. Matsuba, A. Tsuruoka et al., Preventive effects of Cyclosporin on diabetes in NOD mice, Diabetologia, vol.60, issue.4, pp.244-247, 1986.
DOI : 10.1007/BF00454884

J. Miyagawa, K. Yamamoto, T. Hanafusa, N. Itoh, C. Nakagawa et al., Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice, Diabetologia, vol.60, issue.Suppl. 6, pp.503-505, 1990.
DOI : 10.1007/BF00405113

R. Calafiore, G. Basta, A. Falorni, M. Pietropaolo, M. Picchio et al., Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice, Journal of Endocrinological Investigation, vol.322, issue.1, pp.869-873174, 1992.
DOI : 10.1007/BF03348947

F. Nicoletti, M. Borghi, P. Meroni, W. Barcellini, C. Fain et al., Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin, Clinical & Experimental Immunology, vol.2, issue.2, pp.232-236, 1993.
DOI : 10.1111/j.1365-2249.1993.tb05888.x

M. Takahashi, S. Kojima, K. Yamaoka, and E. Niki, Prevention of Type I Diabetes by Low-Dose Gamma Irradiation in NOD Mice, Radiation Research, vol.154, issue.6, pp.680-685, 2000.
DOI : 10.1667/0033-7587(2000)154[0680:POTIDB]2.0.CO;2

A. Bacelj, B. Charlton, and T. Mandel, Prevention of Cyclophosphamide-Induced Diabetes by Anti-V??8 T-Lymphocyte-Receptor Monoclonal Antibody Therapy in NOD/Wehi Mice, Diabetes, vol.38, issue.11, pp.1492-1495, 1989.
DOI : 10.2337/diab.38.11.1492

C. Gearon, M. Hussain, D. Vergani, and M. Peakman, Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus, Diabetologia, vol.40, issue.12, pp.1388-1395, 1997.
DOI : 10.1007/s001250050840

R. Smerdon, M. Peakman, M. Hussain, and D. Vergani, Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse, Immunology, vol.80, pp.498-501, 1993.

B. Formby and T. Shao, T cell vaccination against autoimmune diabetes in nonobese diabetic mice, Ann Clin Lab Sci, vol.23, pp.137-147, 1993.

M. Feili-hariri, M. Frantz, and P. Morel, Prevention of Diabetes in the NOD Mouse by a Th1 Clone Specific for a hsp60 Peptide, Journal of Autoimmunity, vol.14, issue.2, pp.133-142, 2000.
DOI : 10.1006/jaut.1999.0352

M. Vaysburd, C. Lock, and H. Mcdevitt, Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides, Journal of Experimental Medicine, vol.182, issue.3, pp.897-902, 1995.
DOI : 10.1084/jem.182.3.897

T. Taki, M. Nagata, W. Ogawa, N. Hatamori, M. Hayakawa et al., Prevention of Cyclophosphamide-Induced and Spontaneous Diabetes in NOD/Shi/Kbe Mice by Anti-MHC Class I Kd Monoclonal Antibody, Diabetes, vol.40, issue.9, pp.1203-1209, 1991.
DOI : 10.2337/diab.40.9.1203

C. Boitard, A. Bendelac, M. Richard, C. Carnaud, and J. Bach, Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells., Proceedings of the National Academy of Sciences, vol.85, issue.24, pp.9719-9723, 1988.
DOI : 10.1073/pnas.85.24.9719

T. Miyazaki, Y. Matsuda, T. Toyonaga, J. Miyazaki, Y. Yazaki et al., Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules., Proceedings of the National Academy of Sciences, vol.89, issue.20, pp.9519-9523, 1992.
DOI : 10.1073/pnas.89.20.9519

S. Singer, R. Tisch, X. Yang, H. Sytwu, R. Liblau et al., Prevention of diabetes in NOD mice by a mutated I-Ab transgene, Diabetes, vol.47, issue.10, pp.1570-1577, 1998.
DOI : 10.2337/diabetes.47.10.1570

H. Nishimoto, H. Kikutani, K. Yamamura, and T. Kishimoto, Prevention of autoimmune insulitis by expression of I???E molecules in NOD mice, Nature, vol.328, issue.6129, pp.432-434, 1987.
DOI : 10.1038/328432a0

G. Arreaza, M. Cameron, A. Jaramillo, B. Gill, D. Hardy et al., Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism., Journal of Clinical Investigation, vol.100, issue.9, pp.2243-2253, 1997.
DOI : 10.1172/JCI119762

D. Lenschow, S. Ho, H. Sattar, L. Rhee, G. Gray et al., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse, Journal of Experimental Medicine, vol.181, issue.3, pp.1145-1155, 1995.
DOI : 10.1084/jem.181.3.1145

B. Balasa, T. Krahl, G. Patstone, J. Lee, R. Tisch et al., CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice, J Immunol, vol.159, pp.4620-4627, 1997.

Y. Hasegawa, K. Yokono, T. Taki, K. Amano, Y. Tominaga et al., Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb, International Immunology, vol.6, issue.6, pp.831-838, 1994.
DOI : 10.1093/intimm/6.6.831

S. Martin, E. Heidenthal, B. Schulte, H. Rothe, and H. Kolb, Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes, Diabetologia, vol.41, issue.11, pp.1298-1303, 1998.
DOI : 10.1007/s001250051068

P. Hutchings, H. Rosen, O. Reilly, L. Simpson, E. Gordon et al., Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages, Nature, vol.348, issue.6302, pp.639-642, 1990.
DOI : 10.1038/348639a0

M. Debray-sachs, C. Carnaud, C. Boitard, H. Cohen, I. Gresser et al., Prevention of diabetes in NOD mice treated with antibody to murine IFN??, Journal of Autoimmunity, vol.4, issue.2, pp.237-248, 1991.
DOI : 10.1016/0896-8411(91)90021-4

I. Campbell, T. Kay, L. Oxbrow, and L. Harrison, Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice., Journal of Clinical Investigation, vol.87, issue.2, pp.739-742, 1991.
DOI : 10.1172/JCI115055

G. Prudhomme and Y. Chang, Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein, Gene Therapy, vol.6, issue.5, pp.771-777, 1999.
DOI : 10.1038/sj.gt.3300879

V. Kelley, G. Gaulton, M. Hattori, H. Ikegami, G. Eisenbarth et al., Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis, J Immunol, vol.140, pp.59-61, 1988.

X. Zheng, A. Steele, W. Hancock, K. Kawamoto, X. Li et al., IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice, J Immunol, vol.163, pp.4041-4048, 1999.

A. Pacheco-silva, M. Bastos, R. Muggia, O. Pankewycz, J. Nichols et al., Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice, European Journal of Immunology, vol.49, issue.3, pp.697-702, 1992.
DOI : 10.1002/eji.1830220312

K. Fujihira, M. Nagata, H. Moriyama, H. Yasuda, K. Arisawa et al., Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice, Diabetes, vol.49, issue.12, pp.1998-2006, 2000.
DOI : 10.2337/diabetes.49.12.1998

H. Rothe, O. Hara, R. Jr, S. Martin, and H. Kolb, Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40) 2, Diabetologia, vol.40, issue.6, pp.641-646, 1997.
DOI : 10.1007/s001250050728

S. Brod, M. Malone, S. Darcan, M. Papolla, and L. Nelson, Ingested interferon ?? suppresses Type I diabetes in non-obese diabetic mice, Diabetologia, vol.41, issue.10, pp.1227-1232, 1998.
DOI : 10.1007/s001250051056

C. Cailleau, A. Diu-hercend, E. Ruuth, R. Westwood, and C. Carnaud, Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice, Diabetes, vol.46, issue.6, pp.937-940, 1997.
DOI : 10.2337/diabetes.46.6.937

J. Sandberg, D. Eizirik, and S. Sandler, IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice, Clinical and Experimental Immunology, vol.108, issue.2, pp.314-317, 1997.
DOI : 10.1046/j.1365-2249.1997.3771275.x

Q. Wu, B. Salomon, M. Chen, Y. Wang, L. Hoffman et al., Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor, The Journal of Experimental Medicine, vol.231, issue.11, pp.1327-1332, 2001.
DOI : 10.1038/73136

M. Rapoport, A. Jaramillo, D. Zipris, A. Lazarus, D. Serreze et al., Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, Journal of Experimental Medicine, vol.178, issue.1, pp.87-99, 1993.
DOI : 10.1084/jem.178.1.87

DOI : 10.1097/00007890-199508270-00012

K. Pennline, E. Roque-gaffney, and M. Monahan, Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse, Clinical Immunology and Immunopathology, vol.71, issue.2, pp.169-175, 1994.
DOI : 10.1006/clin.1994.1068

P. Zaccone, J. Phillips, I. Conget, R. Gomis, K. Haskins et al., Interleukin-13 prevents autoimmune diabetes in NOD mice, Diabetes, vol.48, issue.8, pp.1522-1528, 1999.
DOI : 10.2337/diabetes.48.8.1522

J. Kim, S. Cho, Y. Kim, E. Jang, S. Park et al., Effects of BCG, lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice, Journal of Korean Medical Science, vol.14, issue.6, pp.648-652, 1999.
DOI : 10.3346/jkms.1999.14.6.648

F. Nicoletti, P. Zaccone, I. Conget, R. Gomis, C. Moller et al., Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice, Diabetes, vol.48, issue.12, pp.2333-2339, 1999.
DOI : 10.2337/diabetes.48.12.2333

B. Formby, C. Jacobs, P. Dubuc, and T. Shao, Exogenous Administration of Il-L?? Inhibits Active and Adoptive Transfer Autoimmune Diabetes in Nod Mice, Autoimmunity, vol.58, issue.1, pp.21-27, 1992.
DOI : 10.1016/S0065-2776(08)60342-9

Z. Zhang, L. Davidson, G. Eisenbarth, and H. Weiner, Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin., Proceedings of the National Academy of Sciences, vol.88, issue.22, pp.10252-10256, 1991.
DOI : 10.1073/pnas.88.22.10252

A. Slavin, R. Maron, and H. Weiner, Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes, International Immunology, vol.13, issue.6, pp.825-833, 2001.
DOI : 10.1093/intimm/13.6.825

D. Daniel and D. Wegmann, Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.956-960, 1996.
DOI : 10.1073/pnas.93.2.956

A. Muir, A. Peck, M. Clare-salzler, Y. Song, J. Cornelius et al., Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription., Journal of Clinical Investigation, vol.95, issue.2, pp.628-634, 1995.
DOI : 10.1172/JCI117707

D. Karounos, J. Bryson, and D. Cohen, Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice., Journal of Clinical Investigation, vol.100, issue.6, pp.1344-1348, 1997.
DOI : 10.1172/JCI119654

I. Urbanek-ruiz, P. Ruiz, V. Paragas, H. Garren, L. Steinman et al., Immunization with DNA Encoding an Immunodominant Peptide of Insulin Prevents Diabetes in NOD Mice, Clinical Immunology, vol.100, issue.2, pp.164-171, 2001.
DOI : 10.1006/clim.2001.5055

M. French, A. J. Cram, D. Thomas, H. Dempsey-collier, M. Silva et al., Transgenic Expression of Mouse Proinsulin II Prevents Diabetes in Nonobese Diabetic Mice, Diabetes, vol.46, issue.1, pp.34-39, 1997.
DOI : 10.2337/diab.46.1.34

I. Bergerot, C. Ploix, J. Petersen, V. Moulin, C. Rask et al., A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes, Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.4610-4614, 1997.
DOI : 10.1073/pnas.93.2.956

V. Ramiya, X. Shang, C. Wasserfall, and N. Maclaren, Effect of Oral and Intravenous Insulin and Glutamic Acid Decarboxylase in NOD Mice, Autoimmunity, vol.78, issue.2, pp.139-151, 1997.
DOI : 10.1080/01621459.1958.10501452

J. Tian, M. Atkinson, C. Salzler, M. Herschenfeld, A. Forsthuber et al., Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes, Journal of Experimental Medicine, vol.183, issue.4, pp.1561-1567, 1996.
DOI : 10.1084/jem.183.4.1561

D. Kaufman, M. Clare-salzler, J. Tian, T. Forsthuber, G. Ting et al., Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes, Nature, vol.366, issue.6450, pp.69-72, 1993.
DOI : 10.1038/366069a0

R. Tisch, X. Yang, S. Singer, R. Liblau, L. Fugger et al., Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice, Nature, vol.366, issue.6450, pp.72-75, 1993.
DOI : 10.1038/366072a0

M. Filippova, J. Liu, and A. Escher, Effects of Plasmid DNA Injection on Cyclophosphamide-Accelerated Diabetes in NOD Mice, DNA and Cell Biology, vol.20, issue.3, pp.175-81, 2001.
DOI : 10.1089/104454901300069022

V. Menard, H. Jacobs, H. Jun, J. Yoon, and S. Kim, Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice, Pharmaceutical Research, vol.16, issue.7, pp.1059-1066, 1999.
DOI : 10.1023/A:1018939900961

D. Elias, D. Markovits, T. Reshef, R. Van-der-zee, and I. Cohen, Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein., Proceedings of the National Academy of Sciences, vol.87, issue.4, pp.1576-1580, 1990.
DOI : 10.1073/pnas.87.4.1576

K. Yamada, K. Nonaka, T. Hanafusa, A. Miyazaki, H. Toyoshima et al., Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice, Diabetes, vol.31, issue.9, pp.749-753, 1982.
DOI : 10.2337/diab.31.9.749

A. Hayward, M. Shriber, and R. Sokol, Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice, J Lab Clin Med, vol.119, pp.503-507, 1992.

E. Heineke, M. Johnson, J. Dillberger, and K. Robinson, Antioxidant MDL 29,311 Prevents Diabetes in Nonobese Diabetic and Multiple Low-Dose STZ-Injected Mice, Diabetes, vol.42, issue.12, pp.1721-1730, 1993.
DOI : 10.2337/diab.42.12.1721

A. Rabinovitch, W. Suarez, and R. Power, Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice, Life Sciences, vol.51, issue.25, pp.1937-1943, 1992.
DOI : 10.1016/0024-3205(92)90110-B

J. Corbett, A. Mikhael, J. Shimizu, K. Frederick, T. Misko et al., Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process., Proceedings of the National Academy of Sciences, vol.90, issue.19, pp.8992-8995, 1993.
DOI : 10.1073/pnas.90.19.8992

L. Liang, E. Beshay, and G. Prud-'homme, The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice, Diabetes, vol.47, issue.4, pp.570-575, 1998.
DOI : 10.2337/diabetes.47.4.570

D. Gross, H. Sidi, L. Weiss, T. Kalland, E. Rosenmann et al., Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug, Diabetologia, vol.53, issue.12, pp.1195-1201, 1994.
DOI : 10.1007/BF00399792

K. Kino, K. Mizumoto, T. Sone, T. Yamaji, J. Watanabe et al., An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice, Diabetologia, vol.141, issue.12, pp.713-718, 1990.
DOI : 10.1007/BF00400340

K. Kida, Y. Kaino, T. Ito, and H. Hirai, Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D- glucan and rhIGF-I, J Pediatr Endocrinol Metab, vol.11, issue.2, pp.327-333, 1998.

A. Panerai, F. Nicoletti, P. Sacedote, L. Arvidsson, I. Conget et al., MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice, Diabetologia, vol.44, issue.7, pp.839-886, 2001.
DOI : 10.1007/s001250100519

J. Krug, E. Lampeter, A. Williams, E. Procaccini, C. Cartledge et al., Immunotherapy with ciamexon in the non obese diabetic (NOD) mouse. Hormone Metab Res, pp.1-4, 1992.

V. Burkart, Y. Kim, M. Kauer, and H. Kolb, Induction of Tolerance in Macrophages by Cholera Toxin B Chain, Pathobiology, vol.67, issue.5-6, pp.314-317, 1999.
DOI : 10.1159/000028088

D. Sobel, B. Yankelevich, D. Goyal, D. Nelson, and A. Mazumder, The B-Subunit of Cholera Toxin Induces Immunoregulatory Cells and Prevents Diabetes in the NOD Mouse, Diabetes, vol.47, issue.2, pp.186-191, 1998.
DOI : 10.2337/diab.47.2.186

J. Meyerovitch, T. Waner, J. Sack, J. Kopolovic, and J. Shemer, Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration, Israel Med Assoc J, vol.2, pp.211-214, 2000.

K. Casteels, C. Mathieu, M. Waer, D. Valckx, L. Overbergh et al., Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D-3 in combination with a short induction course of cyclosporin A, Endocrinology, vol.139, pp.95-102, 1998.

H. Fox, Androgen treatment prevents diabetes in nonobese diabetic mice, Journal of Experimental Medicine, vol.175, issue.5, pp.1409-1412, 1992.
DOI : 10.1084/jem.175.5.1409

A. Andersson, S. Forsgren, A. Soderstrom, and D. Holmberg, Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse, Journal of Autoimmunity, vol.4, issue.5, pp.733-742, 1991.
DOI : 10.1016/0896-8411(91)90169-D

S. Forsgren, A. Andersson, V. Hillorn, A. Soderstrom, and D. Holmberg, Immunoglobulin-Mediated Prevention of Autoimmune Diabetes in the Non-Obese Diabetic (NOD) Mouse, Scandinavian Journal of Immunology, vol.17, issue.4, pp.445-451, 1991.
DOI : 10.1084/jem.135.2.277

I. Krause, Y. Tomer, D. Elias, M. Blank, B. Gilburd et al., Inhibition of Diabetes in NOD Mice by Idiotypic Induction of SLE, Journal of Autoimmunity, vol.13, issue.1, pp.49-55, 1999.
DOI : 10.1006/jaut.1999.0292

J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott et al., Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice, The Journal of Immunology, vol.167, issue.2, pp.1081-1089, 2001.
DOI : 10.4049/jimmunol.167.2.1081

M. Iguchi, H. Inagawa, T. Nishizawa, T. Okutomi, A. Morikawa et al., Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in nonobese diabetic mice by LPSw (a lipopolysaccharide from wheat flour) Chem Pharmaceut Bull, pp.1004-1006, 1992.

L. Hermitte, C. Atlan-gepner, M. Payan, M. Mehelleb, and B. Vialettes, Dietary protection against diabetes in NOD mice: lack of a major change in the immune system, Diabete Metab, vol.21, pp.261-268, 1995.

J. Hoorfar, K. Buschard, D. Hansen, and F. , Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice, British Journal of Nutrition, vol.2, issue.02, pp.597-607, 1993.
DOI : 10.1016/S0022-3476(74)80462-2

K. Buschard, K. Hanspers, P. Fredman, and E. Reich, Treatment with Sulfatide or its Precursor, Galactosylceramide, Prevents Diabetes in NOD Mice, Autoimmunity, vol.188, issue.1, pp.9-17, 2001.
DOI : 10.2337/diab.39.8.933

T. Kobayashi, Q. Song, T. Hong, H. Kitamura, and J. Cyong, Preventive Effect of Ninjin-to (Ren-Shen-Tang), a Kampo (Japanese Traditional) Formulation, on Spontaneous Autoimmune Diabetes in Non-Obese Diabetic (NOD) Mice, Microbiology and Immunology, vol.13, issue.4, pp.299-305, 2000.
DOI : 10.1111/j.1348-0421.2000.tb02499.x

B. Charlton, A. Bacelj, and T. Mandel, Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide, Diabetes, vol.37, issue.7, pp.930-935, 1988.
DOI : 10.2337/diabetes.37.7.930

S. Wilberz, L. Herberg, and A. Renold, Gangliosides in vivo reduce diabetes incidence in non-obese diabetic mice, Diabetologia, vol.31, issue.11, pp.855-857, 1988.
DOI : 10.1007/BF00277490

T. Maruyama, K. Watanabe, I. Takei, A. Kasuga, A. Shimada et al., Antiasialo GM1 antibody suppression of cyclophosphamideinduced diabetes in NOD mice, Diabetes Res, vol.17, pp.37-41, 1991.

R. Pearce and C. Peterson, Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin-dependent diabetes, J Pharmacol Exp Ther, vol.258, pp.710-715, 1991.